Triveni Bio Named to Fierce Biotech's 2025 Fierce 15 | |
Astra Therapeutics Raises CHF 7.75 Million in Seed Financing | |
Triveni Bio Doses First Healthy Volunteers in Clinical Trial for TRIV-509 | |
Compass' Tovecimig (CTX-009) Meets Primary Endpoint in Phase 2/3 Study | |
Ankyra Announces Expansion of Collaboration with J&J to advance IL-12 Anchored Drug Conjugate | |
Ovation.io and Illumina Collaborate to Advance Genomic Data Research | |
